MORAITIS, Andreas G.,COHAN, Pejman,BELANOFF, Joseph K.
申请号:
EP16774094
公开号:
EP3277281A4
申请日:
2016.03.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
This invention provides for a method of treating secondary adrenal insufficiency by co-administrating therapeutically effective amounts of a glucocorticoid and a glucocorticoid receptor antagonist to the patient in need thereof. In some embodiments, the method includes the proviso that the patient not be otherwise in need of treatment with a glucocorticoid and a glucocorticoid receptor antagonist. The treatment method can increase the patient's morning or basal cortisol level to at least about 12 μg/dL or a standard control level, and in turn, expedite significantly the recovery of the HPA axis. The method provided herein can improve health outcomes and life-threatening complications associated with secondary adrenal insufficiency.